RNA-Binding Proteins in Cardiomyopathies

De-Li Shi

DOI: https://doi.org/10.3390/jcdd11030088

2024-03-05

Journal of Cardiovascular Development and Disease

Abstract:The post-transcriptional regulation of gene expression plays an important role in heart development and disease. Cardiac-specific alternative splicing, mediated by RNA-binding proteins, orchestrates the isoform switching of proteins that are essential for cardiomyocyte organization and contraction. Dysfunctions of RNA-binding proteins impair heart development and cause the main types of cardiomyopathies, which represent a heterogenous group of abnormalities that severely affect heart structure and function. In particular, mutations of RBM20 and RBFOX2 are associated with dilated cardiomyopathy, hypertrophic cardiomyopathy, or hypoplastic left heart syndrome. Functional analyses in different animal models also suggest possible roles for other RNA-binding proteins in cardiomyopathies because of their involvement in organizing cardiac gene programming. Recent studies have provided significant insights into the causal relationship between RNA-binding proteins and cardiovascular diseases. They also show the potential of correcting pathogenic mutations in RNA-binding proteins to rescue cardiomyopathy or promote cardiac regeneration. Therefore, RNA-binding proteins have emerged as promising targets for therapeutic interventions for cardiovascular dysfunction. The challenge remains to decipher how they coordinately regulate the temporal and spatial expression of target genes to ensure heart function and homeostasis. This review discusses recent advances in understanding the implications of several well-characterized RNA-binding proteins in cardiomyopathies, with the aim of identifying research gaps to promote further investigation in this field.

cardiac & cardiovascular systems

What problem does this paper attempt to address?

The paper primarily explores the role and mechanisms of RNA-binding proteins (RBPs) in cardiomyopathy. Specifically, the paper attempts to address the following key issues: 1. **Understanding the role of RNA-binding proteins in cardiomyopathy**: - The paper discusses in detail how RNA-binding proteins influence heart development and disease by regulating gene expression. In particular, certain specific RNA-binding proteins such as RBM20, RBM24, and RBPMS are associated with different types of cardiomyopathy (e.g., dilated cardiomyopathy, hypertrophic cardiomyopathy). 2. **Investigating the functions and mutation effects of specific RNA-binding proteins**: - The study examines how mutations in RBM20 affect the structure and function of cardiomyocytes, leading to dilated cardiomyopathy (DCM). For example, mutations in RBM20 can affect the splicing of the Titin gene, thereby altering the stiffness of cardiomyocytes. - It also explores the role of RBM24 in heart development and how its deficiency leads to dilated cardiomyopathy. - Additionally, the roles of RBPMS and RBPMS2 in cardiomyopathy are analyzed, highlighting that their loss can impair the contractile function of cardiomyocytes. 3. **Exploring the potential of RNA-binding proteins as therapeutic targets**: - The paper proposes that correcting pathogenic mutations in RNA-binding proteins or modulating their activity could potentially treat cardiomyopathy or promote heart regeneration. - It discusses methods such as precise base editing to restore RBM20 nuclear localization in animal models. 4. **Identifying research gaps to advance future research**: - The paper points out that there are still unresolved issues in the current knowledge system that require further research to fill these gaps, such as the specific mechanisms of RBM24 in human heart disease. In summary, this paper aims to provide new insights and directions for future cardiovascular disease treatment by deeply studying the mechanisms of RNA-binding proteins in cardiomyopathy.

RNA-Binding Proteins in Cardiomyopathies

RNA binding proteins as mediators of pathological cardiac remodeling

The Biological Mechanisms and Clinical Roles of RNA-Binding Proteins in Cardiovascular Diseases

RNA Binding Proteins: Mechanistic Considerations and Perspectives in Controlling Cardiovascular Diseases

Abstract 18698: PCBP1 Regulates Alternative Splicing of Aars2 in Congenital Cardiomyopathy

Rbm24-mediated post-transcriptional regulation of skeletal and cardiac muscle development, function and regeneration

RBPMS regulates cardiomyocyte contraction and cardiac function through RNA alternative splicing

Mechanisms of RBM20 Cardiomyopathy: Insights From Model Systems

Emerging Role For Rbm20 And Its Splicing Substrates In Cardiac Function And Heart Failure

RNA-binding proteins in cardiovascular biology and disease: the beat goes on

Clinical Insights in RNA-Binding Protein Motif 20 Cardiomyopathy: A Systematic Review

Function Beyond RNA Splicing for RBFox Family Members in Heart

Abstract 13431: Gain-of-Function Mutations in RNA Binding Motif 20 Result in Cardiac Remodelling and Pathogenesis in Mice

Abstract We130: Novel Role of RBFox1 in Myocardial Infarction Induced Heart Failure

SR Protein Kinases Regulate the Splicing of Cardiomyopathy-Relevant Genes via Phosphorylation of the RSRSP Stretch in RBM20

The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets

RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy

RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease

RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction

A Splicing-Independent Function of RBM10 Controls Specific 3' UTR Processing to Regulate Cardiac Hypertrophy

RBM20 Phosphorylation and Its Role in Nucleocytoplasmic Transport and Cardiac Pathogenesis.